Edwards Lifesciences Corp revenue growth has been varied year-over-year.

What is EW's revenue growth rate?

Historical revenue data is available for Edwards Lifesciences Corp to analyze growth trends.

How fast is EW earnings growing?

Earnings growth data is available for Edwards Lifesciences Corp analysis.

What is EW's profit margin?

Profit margin data is available for Edwards Lifesciences Corp.

EW Revenue & Earnings Growth Analysis 2026 - Is Edwards Lifesciences Corp Growing?

Growth Summary

Edwards Lifesciences Corp (EW) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.

Over the past 4 years, Edwards Lifesciences Corp has achieved a revenue compound annual growth rate (CAGR) of 2.3%, while earnings have grown at 1.0% CAGR.

Latest Revenue

$1.39B

Net Income

$385.60M

5-Year Revenue CAGR

2.3%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Edwards Lifesciences Corp

The chart above illustrates Edwards Lifesciences Corp's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Edwards Lifesciences Corp's business.

Profit Margin Trends

How efficiently Edwards Lifesciences Corp converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Edwards Lifesciences Corp retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$2.96

Current: $0.65

EPS Estimate 2027

$3.31

11.8% expected growth

Price Target

$96.46

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Edwards Lifesciences Corp to continue growing earnings in the coming year. The consensus analyst rating is 3.6875 based on 32 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Edwards Lifesciences Corp (EW) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 2.3% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Edwards Lifesciences Corp's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.